Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 7/20 | 0.61 |
| ▸ | STS | P08842 | 4/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.51 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27583513 | 1.00 | HSD17B3 (0.61) | HSD17B3STSHTTFFAR1PLA2G2A | |
| SCHEMBL2187201 | 1.00 | HSD17B3 (0.61) | HSD17B3STSHTTFFAR1PLA2G2A | |
| SCHEMBL296585 | 1.00 | HSD17B3 (0.61) | HSD17B3STSHTTFFAR1PLA2G2A | |
| SCHEMBL27623405 | 1.00 | HSD17B3 (0.61) | HSD17B3STSHTTFFAR1PLA2G2A | |
| Questiomycin B SCHEMBL28071425 | 0.93 | HSD17B3 (0.54) | HSD17B3STSHTTFFAR1PLA2G2A | |
| SCHEMBL2427006 | 0.87 | HSD17B3 (0.56) | HSD17B3STSMEN1ALDH1A1MAPT | |
| SCHEMBL5677489 | 0.85 | HSD17B3 (0.67) | HSD17B3STSHTTFFAR1PLA2G2A | |
| SCHEMBL10489570 | 0.85 | HSD17B3 (0.67) | HSD17B3STSHTTFFAR1PLA2G2A | |
| SCHEMBL10353159 | 0.85 | HSD17B3 (0.67) | HSD17B3STSHTTFFAR1PLA2G2A | |
| SCHEMBL10352970 | 0.85 | HSD17B3 (0.67) | HSD17B3STSHTTFFAR1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 628 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240182674-A1 | USE OF A STABILIZER COMPOSITION FOR STABILIZING HALOGEN-FREE RECYCLED THERMOPLASTICS, STABILIZER COMPOSITION, MASTER BATCH OR CONCENTRATE, STABILIZED PLASTIC COMPOSITION, PROCESS FOR STABILIZING HALOGEN-FREE RECYCLED THERMOPLASTICS, AND USE OF COMPOSITIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-06-06 | — | — | US | claimed |
| CN-106232670-A | Polyurethane foams based on polyether carbonate polyols | 科思创德国股份有限公司 | 2016-12-14 | — | — | CN | claimed |
| CN-1159131-A | Electroluminescent devices | BAYER AG (DE) | 1997-09-10 | — | — | CN | claimed |
| US-20240182674-A1 | USE OF A STABILIZER COMPOSITION FOR STABILIZING HALOGEN-FREE RECYCLED THERMOPLASTICS, STABILIZER COMPOSITION, MASTER BATCH OR CONCENTRATE, STABILIZED PLASTIC COMPOSITION, PROCESS FOR STABILIZING HALOGEN-FREE RECYCLED THERMOPLASTICS, AND USE OF COMPOSITIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-06-06 | — | — | US | disclosed |
| CN-109233189-B | Foam pressing strip for furniture assembly and furniture assembly structure | 尹海涛 | 2024-04-19 | — | — | CN | disclosed |
| US-11407720-B2 | Compounds having a stabilizing effect, method for producing said compounds, composition containing said stabilizing compounds, and uses of the compounds | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2022-08-09 | — | — | US | disclosed |
| US-11358941-B2 | — | — | 2022-06-14 | — | — | US | disclosed |
| US-20200361879-A1 | COMPOUNDS HAVING A STABILIZING EFFECT, METHOD FOR PRODUCING SAID COMPOUNDS, COMPOSITION CONTAINING SAID STABILIZING COMPOUNDS, METHOD FOR STABILIZING AN ORGANIC COMPONENT, AND USE OF STABILIZING COMPOUNDS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) | 2020-11-19 | — | — | US | disclosed |
| US-10759780-B2 | Hindered amines | 3V SIGMA S.P.A. (IT) | 2020-09-01 | — | — | US | disclosed |
| US-20200239629-A1 | HINDERED POLYMERIC AMINES | 3V SIGMA S.P.A. (IT) | 2020-07-30 | — | — | US | disclosed |
| EP-3424977-B1 | HINDERED POLYMERIC AMINES | 3V SIGMA SPA (IT) | 2020-03-18 | — | — | EP | disclosed |
| EP-0512949-A1 | Substituted 2,3-dihydroperimidine stabilizers | CIBA-GEIGY AG (CH) | 1992-11-11 | — | — | EP | disclosed |
| US-5160647-A | High temperature lubricants, heat and oxidation resistance | CIBA-GEIGY CORPORATION (US) | 1992-11-03 | — | — | US | disclosed |
| US-5151459-A | Oxidation resistance for lubricants | CIBA-GEIGY CORPORATION (US) | 1992-09-29 | — | — | US | disclosed |
| US-5147568-A | Oil additives, oxidation and heat resistance | CIBA-GEIGY CORPORATION (US) | 1992-09-15 | — | — | US | disclosed |
| EP-0398843-A1 | Lubricant compositions | CIBA-GEIGY AG (CH) | 1990-11-22 | — | — | EP | disclosed |
| CN-1038299-A | LUBRICATING OIL COMPOSITION | CIBA GEIGY AG (CH) | 1989-12-27 | — | — | CN | disclosed |
| EP-0286595-A2 | Sulfur containing compounds as antioxidants for lubricants and elastomers | CIBA-GEIGY AG (CH) | 1988-10-12 | — | — | EP | disclosed |
| EP-0135927-B1 | ANTIHYPERLIPIDEMIC N-BENZOYLSULFAMATES, N-BENZYLSULFAMATES AND BENZYLSULFONAMIDES, A THERAPEUTIC COMPOSITION CONTAINING SAME AND A PROCESS FOR THE PRODUCTION THEREOF | Research Corporation (US) | 1988-07-06 | — | — | EP | disclosed |
| EP-0135927-A2 | Antihyperlipidemic N-benzoylsulfamates, N-benzylsulfamates and benzylsulfonamides, a therapeutic composition containing same and a process for the production thereof | Research Corporation (US) | 1985-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239629-A1 | HINDERED POLYMERIC AMINES | PARG, PARN, PUF60 | HSD17B3 4464/4885STS 3522/4885HTT 508/4885 |
| US-11407720-B2 | Compounds having a stabilizing effect, method for producing said compounds, composition containing said stabilizing compounds, and uses of the compounds | OGG1, SOD1, ERCC5 | HSD17B3 3923/4885STS 3062/4885HTT 1089/4885 |
| US-11358941-B2 | — | OGG1, SOD1, ERCC5 | HSD17B3 3419/4885STS 2569/4885HTT 1274/4885 |
| US-20200361879-A1 | COMPOUNDS HAVING A STABILIZING EFFECT, METHOD FOR PRODUCING SAID COMPOUNDS, COMPOSITION CONTAINING SAID STABILIZING COMPOUNDS, METHOD FOR STABILIZING AN ORGANIC COMPONENT, AND USE OF STABILIZING COMPOUNDS | OGG1, SOD1, AOX1 | HSD17B3 3752/4885STS 2653/4885HTT 1518/4885 |
| US-10759780-B2 | Hindered amines | PARG, TAAR5, PARN | HSD17B3 4018/4885STS 1993/4885HTT 616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.